Important Role of Endogenous Nerve Growth Factor Receptor in the Pathogenesis of Hypoxia-Induced Pulmonary Hypertension in Mice
暂无分享,去创建一个
S. Kaneko | S. Usui | M. Takamura | K. Sakata | O. Inoue | S. Takashima | A. Nomura | K. Yamaguchi | Yusuke Takeda | C. Goten | D. Hashimuko
[1] F. Soubrier,et al. Progenitor/Stem Cells in Vascular Remodeling during Pulmonary Arterial Hypertension , 2021, Cells.
[2] Yusuke Kodama,et al. Fibrinolytic markers could be useful predictors of severity in patients with pulmonary arterial hypertension: a retrospective study , 2021, Thrombosis Journal.
[3] S. Kaneko,et al. Circulating nerve growth factor receptor positive cells are associated with severity and prognosis of pulmonary arterial hypertension , 2021, Pulmonary circulation.
[4] M. Humbert,et al. Targeting transforming growth factor-β receptors in pulmonary hypertension , 2020, European Respiratory Journal.
[5] C. Ruppert,et al. BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGFβ responses and altered cell mechanics , 2019, PLoS biology.
[6] S. Kaneko,et al. Sphigosine-1-phosphate receptor 1 promotes neointimal hyperplasia in a mouse model of carotid artery injury. , 2019, Biochemical and biophysical research communications.
[7] L. Bracci-Laudiero,et al. NGF and Its Receptors in the Regulation of Inflammatory Response , 2017, International journal of molecular sciences.
[8] Sally L Elshaer,et al. Implication of the neurotrophin receptor p75NTR in vascular diseases: beyond the eye , 2017, Expert review of ophthalmology.
[9] G. Inman,et al. TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling , 2017, Nature Communications.
[10] M. Honda,et al. Altered gene expression in T-cell receptor signalling in peripheral blood leucocytes in acute coronary syndrome predicts secondary coronary events , 2016, Open Heart.
[11] M. Humbert,et al. Role of Nerve Growth Factor in Development and Persistence of Experimental Pulmonary Hypertension. , 2015, American journal of respiratory and critical care medicine.
[12] I. Komuro,et al. Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension , 2015, Proceedings of the National Academy of Sciences.
[13] M. Humbert,et al. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. , 2014, Circulation research.
[14] D. Moertl,et al. Markers of Thrombogenesis and Fibrinolysis and Their Relation to Inflammation and Endothelial Activation in Patients with Idiopathic Pulmonary Arterial Hypertension , 2013, PloS one.
[15] H. Ghofrani,et al. Mechanisms of disease: pulmonary arterial hypertension , 2011, Nature Reviews Cardiology.
[16] R. Trembath,et al. Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension , 2010, Circulation.
[17] S. Eddahibi,et al. Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice , 2009, Respiratory research.
[18] A. Görlach,et al. The ‘PAI-1 paradox’ in vascular remodelling , 2008, Thrombosis and Haemostasis.
[19] G. Spinetti,et al. Neurotrophin p75 Receptor (p75NTR) Promotes Endothelial Cell Apoptosis and Inhibits Angiogenesis: Implications for Diabetes-Induced Impaired Neovascularization in Ischemic Limb Muscles , 2008, Circulation research.
[20] G. Diller,et al. Circulating Endothelial Progenitor Cells in Patients With Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension , 2008, Circulation.
[21] R. Tuder,et al. Pathology of pulmonary hypertension. , 2007, Clinics in chest medicine.
[22] W. Vainchenker,et al. Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice , 2007, Respiratory research.
[23] S. Mieno,et al. Implantation of Mesenchymal Stem Cells Overexpressing Endothelial Nitric Oxide Synthase Improves Right Ventricular Impairments Caused by Pulmonary Hypertension , 2006, Circulation.
[24] M. Frid,et al. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. , 2006, The American journal of pathology.
[25] Qingbo Xu,et al. Smooth Muscle Cells in Transplant Atherosclerotic Lesions Are Originated From Recipients, but Not Bone Marrow Progenitor Cells , 2002, Circulation.
[26] Y. Barde,et al. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. , 2000, Genes & development.
[27] S. Kaneko,et al. Endogenous muscle atrophy F-box is involved in the development of cardiac rupture after myocardial infarction. , 2019, Journal of molecular and cellular cardiology.